Results 21 to 30 of about 136,887 (323)

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.

open access: yesJournal of the American Medical Association (JAMA), 2022
Importance Vaccination against COVID-19 provides clear public health benefits, but vaccination also carries potential risks. The risks and outcomes of myocarditis after COVID-19 vaccination are unclear.
M. Oster   +25 more
semanticscholar   +1 more source

Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study

open access: yesFrontiers in Immunology, 2022
Background and ObjectiveImmune checkpoint inhibitor (ICI)-associated myocarditis is a fatal immune-related adverse events (irAEs), which is prone to affecting multiple organ systems.
Xiaohong Xie   +16 more
doaj   +1 more source

Myocarditis [PDF]

open access: yesCirculation, 1954
A review of selected papers on myocarditis published during the past decade and an analysis of some original data together with personal experiences have been presented. All of these indicate that the clinical diagnosis of myocarditis is made far too infrequently as contrasted with the high incidence of this disease as recognized by ...
C E, DE LA CHAPELLE, C E, KOSSMANN
openaire   +2 more sources

COVID myocarditis: a review of the literature

open access: yesMonaldi Archives for Chest Disease, 2023
Myocarditis is a potentially fatal complication of coronavirus disease 2019 (COVID‐19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. COVID‐19 myocarditis appears to have distinct inflammatory characteristics
Angelica Cersosimo   +4 more
doaj   +1 more source

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

open access: yesNew England Journal of Medicine, 2021
Background Approximately 5.1 million Israelis had been fully immunized against coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) by May 31, 2021.
D. Mevorach   +26 more
semanticscholar   +1 more source

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

open access: yesNature Medicine, 2021
Although myocarditis and pericarditis were not observed as adverse events in coronavirus disease 2019 (COVID-19) vaccine trials, there have been numerous reports of suspected cases following vaccination in the general population.
M. Patone   +13 more
semanticscholar   +1 more source

COVID-19 and myocarditis: a review of literature

open access: yesThe Egyptian Heart Journal, 2022
Myocarditis has been discovered to be a significant complication of coronavirus disease 2019 (COVID-19), a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus.
Mohammed Ali   +8 more
doaj   +1 more source

Myocarditis [PDF]

open access: yesThe Lancet, 2012
Myocarditis is an underdiagnosed cause of acute heart failure, sudden death, and chronic dilated cardiomyopathy. In developed countries, viral infections commonly cause myocarditis; however, in the developing world, rheumatic carditis, Trypanosoma cruzi, and bacterial infections such as diphtheria still contribute to the global burden of the disease ...
Sandeep, Sagar   +2 more
openaire   +2 more sources

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

open access: yesMMWR. Morbidity and mortality weekly report, 2021
In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine and the Moderna COVID-19 (mRNA-1273) vaccine,† and the Advisory Committee on Immunization Practices ...
PhD Julia W. Gargano   +19 more
semanticscholar   +1 more source

Myocarditis

open access: yesNew England Journal of Medicine, 2022
According to the 1995 World Health Organization task force on cardiomyopathies, myocarditis is an inflammatory disease of the myocardium that is diagnosed on the basis of established histologic, immunologic, and immunohistochemical criteria. Since the introduction of the Dallas criteria in 1987, endomyocardial biopsy has been considered the standard ...
Andreas, Schuster, Sebastian, Kelle
openaire   +4 more sources

Home - About - Disclaimer - Privacy